Compound
BPC-157
Synthetic research peptide
What it is
BPC-157 is a synthetic peptide fragment marketed for recovery and longevity purposes, largely on the basis of animal data.[1] It is sold in research-chemical channels with 'not for human consumption' labeling.
Regulatory status
No FDA approval. No USP/NF monograph. Under FDA bulk-substance (503A) review, with Category 2 status citing significant safety risk concerns warranting further evaluation.[2] WADA lists BPC-157 as non-approved (S0), prohibited at all times.[3]
State of the evidence
A large preclinical literature in rodents on tissue-repair endpoints, consistent across multiple laboratories. As of early 2026, only a small number of human pilot studies — far short of the evidence required for regulatory approval.[1] This is an open evidence gap, not a settled result.
Sources
Educational reference only. Not medical advice. No dosing or protocols are published here.
Newsletter
The science, in your inbox.
Sourced explainers on peptides and biohacking. No hype, no claims — just the research, parsed. One email a week.
Research summaries, not medical advice. Unsubscribe anytime.